Oncodesign Precision Medicine (OPM) Announces its IPO Throug

Direct listing of OPM on Euronext Access Paris on 5 October 2022 Q&A available (only in French): click here Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63;

Related Keywords

Paris , France General , France , French , Arthur Rouill , Mathilde Bohin , Philippe Genne , Euronext , Euronext Access Paris , Precision Medicine , Euronext Paris , Euronext Access , Euronext Growth , Oncodesign Precision Medicine , Mrs Catherine , Mrs Aliz , Oncodesign , Precision , Medicine , Nnounces , Through , Direct , Listing , Uronext , Access ,